Are you Dr. Berhe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 76 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3409 Worth St
710
Dallas, TX 75246Phone+1 214-823-2533Fax+1 214-824-8679- Is this information wrong?
Summary
- Dr. Mezgebe Berhe, MD is an infectious disease specialist in Dallas, Texas. He is currently licensed to practice medicine in Texas and Virginia. He is affiliated with Baylor University Medical Center, Baylor Scott & White Medical Center-Uptown, and Texas Health Presbyterian Hospital Dallas.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 2003 - 2005
St Barnabas HospitalResidency, Internal Medicine, 2000 - 2003
Addis Ababa University Faculty of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 2005 - 2024
VA State Medical License 2003 - 2006- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011-2013
Publications & Presentations
PubMed
- 4 citationsSustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.Charlotte-Paige Rolle, Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson Wurapa, Moti Ramgopal, Dushyantha T Jayaweera, Peter A Leone, Jessica E Matthews, Michael Cupo...> ;Open Forum Infectious Diseases. 2023 Mar 1
- 20 citationsLenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-c...Samir K Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal, James Sims, Cheryl McDonald, Peter Ruane, William E Sanchez, Anita Scribner, Shan-Yu Liu, Lau...> ;The Lancet. HIV. 2023 Jan 1
- 1 citationsEffect on SARS-CoV-2 viral load using combination therapy with casirivimab/imdevimab and remdesivir.Vivek K Kataria, Mezgebe Berhe, Uriel Sandkovsky> ;Proceedings. 2022 Jan 1
- Join now to see all
Press Mentions
Booster Shot May Be on Horizon for J&J Vaccine RecipientsAugust 25th, 2021- NTIDC Researchers: Pfizer Vaccine Is Safe, Ready to GoNovember 27th, 2020
- More Than 2,500 Healthcare Providers Sign up to Administer Coronavirus Vaccine in TexasNovember 11th, 2020
- Join now to see all
Hospital Affiliations
- Baylor Scott & White Medical Center-UptownDallas, Texas
Baylor University Medical CenterDallas, Texas- Dallas Medical CenterDallas, Texas
Texas Health Presbyterian Hospital DallasDallas, Texas
